Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bauersachs

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Cardiovascular Therapeutics|February 27, 2020
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature ReviewRupert Bauersachs, Uwe Zeymer, Jean-Baptiste Brière, et al.
Journal of Thrombosis and Thrombolysis|March 15, 2016
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trialSebastian Werth, Rupert Bauersachs, Horst Gerlach, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 6, 2020
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA)Birgit Linnemann, Rupert Bauersachs, Mathias Grebe, et al.
Hamostaseologie|June 27, 2020
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Christina Hart, Rupert Bauersachs, Ute Scholz, et al.
Cardiovascular Therapeutics|September 9, 2021
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-AnalysisRupert Bauersachs, Olivia Wu, Neil Hawkins, et al.
Angiology|December 5, 2022
The Role of Anticoagulants and Platelet Aggregation Inhibitors in the Treatment of Pseudoaneurysms and Risk of Venous ThrombosisJonas Juenger, Adrian Mahlmann, Andrei Udelnow, et al.
European Journal of Internal Medicine|January 31, 2014
The quality of oral anticoagulation in general practice in patients with atrial fibrillationSabrina Mueller, Matthias Pfannkuche, Günter Breithardt, et al.
Hamostaseologie|February 12, 2026
Thrombophilia Testing in Women and Adolescent Girls-Position Paper from the Standing Committee on Women's Health Issues of the Society for Thrombosis and Haemostasis Research (GTH)Birgit Linnemann, Rupert Bauersachs, Frauke Bergmann, et al.
Angiology|December 31, 2019
A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery DiseaseRupert Bauersachs, Sebastian Debus, Mark Nehler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 13, 2021
High incidence of deep vein thrombosis during the treatment of pseudoaneurysms - a retrospective nonrandomized studyJoerg Herold, Sophie Peters, Jonas Juenger, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Cardiovascular Therapeutics|February 27, 2020
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature ReviewRupert Bauersachs, Uwe Zeymer, Jean-Baptiste Brière, et al.
Journal of Thrombosis and Thrombolysis|March 15, 2016
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trialSebastian Werth, Rupert Bauersachs, Horst Gerlach, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 6, 2020
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA)Birgit Linnemann, Rupert Bauersachs, Mathias Grebe, et al.
Hamostaseologie|June 27, 2020
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Christina Hart, Rupert Bauersachs, Ute Scholz, et al.
Cardiovascular Therapeutics|September 9, 2021
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-AnalysisRupert Bauersachs, Olivia Wu, Neil Hawkins, et al.
Angiology|December 5, 2022
The Role of Anticoagulants and Platelet Aggregation Inhibitors in the Treatment of Pseudoaneurysms and Risk of Venous ThrombosisJonas Juenger, Adrian Mahlmann, Andrei Udelnow, et al.
European Journal of Internal Medicine|January 31, 2014
The quality of oral anticoagulation in general practice in patients with atrial fibrillationSabrina Mueller, Matthias Pfannkuche, Günter Breithardt, et al.
Hamostaseologie|February 12, 2026
Thrombophilia Testing in Women and Adolescent Girls-Position Paper from the Standing Committee on Women's Health Issues of the Society for Thrombosis and Haemostasis Research (GTH)Birgit Linnemann, Rupert Bauersachs, Frauke Bergmann, et al.
Angiology|December 31, 2019
A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery DiseaseRupert Bauersachs, Sebastian Debus, Mark Nehler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 13, 2021
High incidence of deep vein thrombosis during the treatment of pseudoaneurysms - a retrospective nonrandomized studyJoerg Herold, Sophie Peters, Jonas Juenger, et al.
Pageof 14